Literature DB >> 33597945

The Important Role of Leptin in Modulating the Risk of Dermatological Diseases.

Xin Su1, Ye Cheng1, Dong Chang1.   

Abstract

It is an indisputable fact that obesity is associated with a series of health problems. One important hallmark of obesity is excessive accumulation of lipids in the adipocyte, especially triglyceride (TG). Currently, the adipocyte has been considered not only as a huge repository of excess energy in the form of fat but also as an important source of multiple hormones and cytokines called adipokines. In obesity, the adipocyte is dysfunctional with excessive production and secretion of pro-inflammatory adipokines, such as tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and leptin. On the other hand, accumulating evidence has shown that leptin plays a vital role in stimulating angiogenesis, controlling lipid metabolism, and modulating the production of pro-inflammatory cytokines. Furthermore, the various activities of leptin are related to the wide distribution of leptin receptors. Notably, it has been reported that enhanced leptin levels and dysfunction of the leptin signaling pathway can influence diverse skin diseases. Recently, several studies revealed the roles of leptin in wound healing, the hair cycle, and the pathogenic development of skin diseases, such as psoriasis, lupus erythematosus, and dermatological cancers. However, the exact mechanisms of leptin in modulating the dermatological diseases are still under investigation. Therefore, in the present review, we summarized the regulatory roles of leptin in the pathological progression of diverse diseases of skin and skin appendages. Furthermore, we also provided evidence to elucidate the complicated relationship between leptin and different dermatological diseases, such as systemic lupus erythematosus (SLE), psoriasis, hidradenitis suppurativa, and some skin tumors.
Copyright © 2021 Su, Cheng and Chang.

Entities:  

Keywords:  dermatological diseases; immune system; leptin; leptin receptor; obesity

Mesh:

Substances:

Year:  2021        PMID: 33597945      PMCID: PMC7882601          DOI: 10.3389/fimmu.2020.593564

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  98 in total

Review 1.  Leptin resistance and hippocampal behavioral deficits.

Authors:  Catherine Van Doorn; Victoria A Macht; Claudia A Grillo; Lawrence P Reagan
Journal:  Physiol Behav       Date:  2017-03-04

Review 2.  Inflammatory mechanisms linking obesity and metabolic disease.

Authors:  Alan R Saltiel; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

3.  New insight into sortilin in controlling lipid metabolism and the risk of atherogenesis.

Authors:  Xin Su; Daoquan Peng
Journal:  Biol Rev Camb Philos Soc       Date:  2019-10-18

4.  Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

Authors:  Luigi Naldi; Liliane Chatenoud; Dennis Linder; Anna Belloni Fortina; Andrea Peserico; Anna Rosa Virgili; Pier Luigi Bruni; Vito Ingordo; Giovanni Lo Scocco; Carmen Solaroli; Donatella Schena; Annalisa Barba; Anna Di Landro; Enrico Pezzarossa; Fabio Arcangeli; Claudia Gianni; Roberto Betti; Paolo Carli; Alessandro Farris; Gian Franco Barabino; Carlo La Vecchia
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

5.  Inflammatory "adiposopathy" in major amputation patients.

Authors:  Christine R Mauro; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki
Journal:  Ann Vasc Surg       Date:  2013-04       Impact factor: 1.466

Review 6.  Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity.

Authors:  A Stofkova
Journal:  Endocr Regul       Date:  2009-10

Review 7.  The soluble leptin receptor.

Authors:  Michael Schaab; Juergen Kratzsch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-09-06       Impact factor: 4.690

8.  Lack of association between leptin, leptin receptor, adiponectin gene polymorphisms and epicardial adipose tissue, abdominal visceral fat volume and atherosclerotic burden in psoriasis patients.

Authors:  Tiago Torres; Nuno Bettencourt; Joana Ferreira; Cláudia Carvalho; Denisa Mendonça; Carlos Vasconcelos; Manuela Selores; Berta Silva
Journal:  Arch Physiol Biochem       Date:  2015-06-30       Impact factor: 4.076

Review 9.  Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist.

Authors:  Luigi Barrea; Francesca Nappi; Carolina Di Somma; Maria Cristina Savanelli; Andrea Falco; Anna Balato; Nicola Balato; Silvia Savastano
Journal:  Int J Environ Res Public Health       Date:  2016-07-22       Impact factor: 3.390

10.  Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.

Authors:  Anna Stochmal; Joanna Czuwara; Michał Zaremba; Lidia Rudnicka
Journal:  Arch Dermatol Res       Date:  2019-10-30       Impact factor: 3.017

View more
  2 in total

1.  Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.

Authors:  Giorgiana Negrea; Valentin-Florian Rauca; Marta Szilvia Meszaros; Laura Patras; Lavinia Luput; Emilia Licarete; Vlad-Alexandru Toma; Alina Porfire; Dana Muntean; Alina Sesarman; Manuela Banciu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

Review 2.  Exploring the Links between Obesity and Psoriasis: A Comprehensive Review.

Authors:  Gabriela Barros; Pablo Duran; Ivana Vera; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-07-06       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.